应用在体剂量学识别需要自适应放疗的头颈癌患者
该回顾性研究纳入182例头颈癌患者,评估基于电子射野影像装置的在体剂量学(EIVD)检测需要自适应放疗(ART)患者的敏感性并识别其局限。50例接受ART的患者中,A、B、C组分别有1/1、6/10、23/39例在ART前出现失败分次;%GP最佳截断值为旧/新机器95%/95.2%。结论认为EIVD联合3D影像技术可协同检测从头颈癌患者解剖变化中获益于ART者。
要点
- 在体剂量学可检测头颈癌放疗中需要自适应放疗的解剖变化。
- %GP最佳截断值为旧机器95%、新机器95.2%(3%剂量差、3 mm吻合距离)。
- C组1例无失败分次者仍有显著剂量学变化(假阴性)。
核心结论
- EIVD联合3D影像技术可协同检测头颈癌患者中获益于ART的解剖变化。
研究设计与样本
- 回顾性研究纳入182例头颈癌患者,分为A组(无 elective 淋巴结的喉癌)、B组(术后放疗)、C组(包括 elective 淋巴结的原发放疗)。
- 采用受试者工作特征曲线获取%GP的最佳截断值,剂量差3%、吻合距离3 mm。
主要发现
- 50例接受ART的头颈癌患者中,A组1例、B组10例、C组39例。
- ART前失败分次发生率:A组1/1、B组6/10、C组23/39。
- B组4例无失败分次者仅见轻微剂量学变化;C组1例无失败分次者出现显著剂量学变化(假阴性)。
- 3例因EIVD无法检测的临床原因接受ART。
- %GP最佳截断值:旧机器95%、新机器95.2%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Head and neck cancer (HNC) patients experiencing anatomical changes during their radiotherapy (RT) course may benefit from adaptive RT (ART). We investigated the sensitivity of an electronic portal imaging device (EPID)-based in-vivo dosimetry (EIVD) system to detect patients that require ART and identified its limitations. MATERIALS AND METHODS: A retrospective study was conducted for 182 HNC patients: laryngeal cancer without elective lymph nodes (group A), postoperative RT (group B) and primary RT including elective lymph nodes (group C). The effect of anatomical changes on the dose distribution and volumetric changes was quantified. The receiver operating characteristic curve was used to obtain the optimal cut-off value for the gamma passing rate (%GP) with a dose difference of 3% and a distance to agreement of 3 mm. RESULTS: Fifty HNC patients receiving ART were analyzed: 1 in group A, 10 in group B and 39 in group C. Failed fractions (FFs) occurred in 1/1, 6/10 and 23/39 cases before ART in group A, B and C respectively. In the four cases in group B without FFs, only minor dosimetric changes were observed. One of the cases in group C without FFs had significant dosimetric changes (false negative). Three cases received ART because of clinical reasons that cannot be detected by EIVD. The optimal cut-off value for the %GP was 95%/95.2% for old/new generation machines respectively. CONCLUSION: EIVD combined with 3D imaging techniques can be synergistic in the detection of anatomical changes in HNC patients who benefit from ART.
引用
- Fiagan YAC, Bossuyt E, Nevens D, et al. The use of in-vivo dosimetry to identify head and neck cancer patients needing adaptive radiotherapy. Radiother Oncol. 2023. PMID: 37084887. doi:10.1016/j.radonc.2023.109676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。